Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_provenance.
- NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_assertion description "[EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_provenance.
- NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_assertion evidence source_evidence_literature NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_provenance.
- NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_assertion SIO_000772 19850635 NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_provenance.
- NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_assertion wasDerivedFrom gad-20150221 NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_provenance.
- NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_assertion wasGeneratedBy ECO_0000203 NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_provenance.
- gad-20150221 importedOn "2015-02-21" NP158421.RADDzh7rpXymQZBiEsGAQY0pHaXNLI2aPGSzpXUpR2suE130_provenance.